Posted by
Ketamine and Future Depression Treatments

Ketamine and Future Depression Treatments

Researchers are hailing ketamine as the most significant new development in psychiatry given its high efficacy for treating major depression. Recent evidence has shown that in addition to depression, ketamine may also be a promising treatment for obsessive-compulsive disorder, post-traumatic stress disorder, and a number of other treatment-refractory neuropsychiatric disorders. In a recent paper published in Drug Discovery […]

Posted by
FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety

FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety

Agency is expediting work to evaluate regulatory policies related to cannabis and cannabis-derived ingredients like CBD Today, the U.S. Food and Drug Administration announced that it has issued a warning letter to Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid […]

Posted by
Flashing Lights and Odd-Ball Beeps: The Tools that Help PASWFL Map and Treat Depression

Flashing Lights and Odd-Ball Beeps: The Tools that Help PASWFL Map and Treat Depression

Quantitative Electroencephalograms (QEEG’s) Help us ‘See’ Depression QEEGs have allowed us to repurpose existing neurological tests to help us better diagnose and treat major depressive, and related, disorders. Until now, we have bolstered a solid history and mental status examination with direct patient queries, objective written tests and scales. Technology and neurochemistry have given us […]

Posted by
AMA: Do Not Use Electronic Cigarettes

AMA: Do Not Use Electronic Cigarettes

HealthDay News – Americans should not use electronic cigarettes while health officials investigate cases of severe lung illness that may be linked to the devices, according to a statement issued by Patrice A. Harris, MD, president of the American Medical Association. “In light of increasing reports of e-cigarette-associated lung illnesses across the country, the AMA […]

Posted by
Unlocking the Mysteries of the Glutamate System

Unlocking the Mysteries of the Glutamate System

Ketamine, Similar Compounds Emerging as Mood Disorder Treatments Sanjay J. Mathew, MD, vice chair for research at Baylor College of Medicine and staff physician at the Michael E. Debakey VA Medical Center in Houston, Texas, has long been interested in the brain’s glutamate system and how it could be manipulated with substances such as ketamine to […]

Posted by
Trial of SAGE-217 in Patients with Major Depressive Disorder

Trial of SAGE-217 in Patients with Major Depressive Disorder

Handan Gunduz-Bruce, M.D.,  Christopher Silber, M.D.,  Inder Kaul, M.D.,  Anthony J. Rothschild, M.D.,  Robert Riesenberg, M.D.,  Abdul J. Sankoh, Ph.D.,  Haihong Li, Ph.D.,  Robert Lasser, M.D.,  Charles F. Zorumski, M.D.,  David R. Rubinow, M.D.,  Steven M. Paul, M.D.,  Jeffrey Jonas, M.D.,  et al. Abstract BACKGROUND Altered neurotransmission of γ-aminobutyric acid (GABA) has been implicated in […]